Go Pro
→ Earth's biggest energy source: near Grand Canyon (From Behind the Markets) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
$8.53
-1.0%		$8.87
$3.30
▼
$11.06
$840.09M1.8611,739 shs681,935 shs
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
$17.42
-9.9%		$17.30
$8.80
▼
$32.71
$869.65M3.37983,614 shs848,149 shs
Electromed, Inc. stock logo
ELMD
Electromed
$27.07
-1.6%		$38.99
$23.01
▼
$47.40
$230.15M0.4677,109 shs78,100 shs
InMode Ltd. stock logo
INMD
InMode
$14.79
-0.1%		$15.07
$12.72
▼
$16.74
$851.29M1.86427,067 shs621,118 shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
-1.04%-0.70%-4.80%-8.38%+83.84%
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
-9.88%-10.30%+6.22%+18.58%-30.32%
Electromed, Inc. stock logo
ELMD
Electromed
-1.60%-4.14%-36.43%-28.02%+1.73%
InMode Ltd. stock logo
INMD
InMode
-0.14%-1.07%-2.63%+9.64%-1.86%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
$8.53
-1.0%		$8.87
$3.30
▼
$11.06
$840.09M1.8611,739 shs681,935 shs
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
$17.42
-9.9%		$17.30
$8.80
▼
$32.71
$869.65M3.37983,614 shs848,149 shs
Electromed, Inc. stock logo
ELMD
Electromed
$27.07
-1.6%		$38.99
$23.01
▼
$47.40
$230.15M0.4677,109 shs78,100 shs
InMode Ltd. stock logo
INMD
InMode
$14.79
-0.1%		$15.07
$12.72
▼
$16.74
$851.29M1.86427,067 shs621,118 shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
-1.04%-0.70%-4.80%-8.38%+83.84%
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
-9.88%-10.30%+6.22%+18.58%-30.32%
Electromed, Inc. stock logo
ELMD
Electromed
-1.60%-4.14%-36.43%-28.02%+1.73%
InMode Ltd. stock logo
INMD
InMode
-0.14%-1.07%-2.63%+9.64%-1.86%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
2.60
Moderate Buy$16.0087.57% Upside
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
2.50
Moderate Buy$20.1015.38% Upside
Electromed, Inc. stock logo
ELMD
Electromed
2.75
Moderate Buy$43.7561.62% Upside
InMode Ltd. stock logo
INMD
InMode
2.00
Hold$16.008.18% Upside

Current Analyst Ratings Breakdown

Latest ELMD, AVR, BBNX, and INMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/26/2026
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
8/26/2026
Electromed, Inc. stock logo
ELMD
Electromed
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$50.00
8/26/2026
Electromed, Inc. stock logo
ELMD
Electromed
Lake Street Capital logo
Lake Street Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$36.00 ➝ $47.00
8/21/2026
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
William Blair logo
William Blair
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageMarket Perform
8/18/2026
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
8/14/2026
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
Cantor Fitzgerald logo
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$15.00
8/6/2026
InMode Ltd. stock logo
INMD
InMode
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D+)
7/28/2026
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$22.00
7/17/2026
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
7/15/2026
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
The Goldman Sachs Group, Inc. logo
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$17.00 ➝ $19.00
7/13/2026
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$18.00 ➝ $22.00
(Data available from 9/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
$1.91M435.25N/AN/A($0.01) per share-853.00
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
$100.25M7.82N/AN/A$6.53 per share2.67
Electromed, Inc. stock logo
ELMD
Electromed
$73.78M3.07$0.65 per share41.36$5.10 per share5.31
InMode Ltd. stock logo
INMD
InMode
$370.49M2.29$1.49 per share9.93$10.78 per share1.37
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
-$94.14M-$1.95N/AN/AN/A-4,619.27%-77.69%-67.99%11/11/2026 (Estimated)
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
-$73.20M-$1.65N/AN/AN/A-61.31%-26.30%-23.25%N/A
Electromed, Inc. stock logo
ELMD
Electromed
$5.15M$1.3136.09N/AN/A11.34%15.71%13.37%N/A
InMode Ltd. stock logo
INMD
InMode
$93.83M$1.2312.02N/AN/A20.69%11.99%10.60%10/28/2026 (Estimated)

Latest ELMD, AVR, BBNX, and INMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/11/2026Q2 2026 TU
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
-$0.2073-$0.30-$0.0927-$0.30$1.50 million$1.01 million
8/5/2026Q2 2026
InMode Ltd. stock logo
INMD
InMode
$0.3460$0.35+$0.0040$0.29$94.89 million$95.59 million
7/29/2026Q2 2026
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
-$0.62-$0.53+$0.09-$0.53N/A$32.01 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
N/AN/AN/AN/AN/A
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
N/AN/AN/AN/AN/A
Electromed, Inc. stock logo
ELMD
Electromed
N/AN/AN/AN/AN/A
InMode Ltd. stock logo
INMD
InMode
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
N/A
14.20
14.20
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
N/A
8.88
7.96
Electromed, Inc. stock logo
ELMD
Electromed
N/A
5.10
4.74
InMode Ltd. stock logo
INMD
InMode
N/A
8.18
7.28

Institutional Ownership

CompanyInstitutional Ownership
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
N/A
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
N/A
Electromed, Inc. stock logo
ELMD
Electromed
40.82%
InMode Ltd. stock logo
INMD
InMode
68.04%

Insider Ownership

CompanyInsider Ownership
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
4.50%
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
5.30%
Electromed, Inc. stock logo
ELMD
Electromed
10.50%
InMode Ltd. stock logo
INMD
InMode
6.92%
CompanyEmployeesShares OutstandingFree FloatOptionable
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
13897.46 million93.07 millionN/A
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
29444.99 million42.61 millionN/A
Electromed, Inc. stock logo
ELMD
Electromed
1608.37 million7.36 millionOptionable
InMode Ltd. stock logo
INMD
InMode
48057.48 million53.50 millionOptionable

Recent News About These Companies

InMode Ltd. (NASDAQ:INMD) Given Consensus Rating of "Hold" by Analysts
 |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31013918
InMode Ltd. (NASDAQ:INMD) Receives Average Rating of "Hold" from Brokerages
 |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-inmode-ltd-nasdaq-inmd-receives-average-rating-of-hold-from-brokerages-2026-09-10/
InMode Advances RF Microneedling Comfort with the Launch of Morpheus8 Cool
September 9 at 8:05 AM  |  prnewswire.comhttps://www.prnewswire.com/news-releases/inmode-advances-rf-microneedling-comfort-with-the-launch-of-morpheus8-cool-302872766.html
Bank of America Corp DE Sells 236,577 Shares of InMode Ltd. $INMD
September 8 at 3:35 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-bank-of-america-corp-de-sells-236577-shares-of-inmode-ltd-inmd-2026-09-08/
InMode (NASDAQ:INMD) Share Price Crosses Above 200-Day Moving Average - Here's Why
September 2, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30997917
InMode (NASDAQ:INMD) Stock Crosses Above Two Hundred Day Moving Average - What's Next?
September 2, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-inmode-nasdaq-inmd-stock-crosses-above-two-hundred-day-moving-average-whats-next-2026-09-02/
InMode (NASDAQ:INMD) Stock Price Crosses Above 200-Day Moving Average - Here's Why
August 25, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-inmode-nasdaq-inmd-stock-price-crosses-above-200-day-moving-average-heres-why-2026-08-25/
InMode Ltd. (NASDAQ:INMD) Given Average Recommendation of "Hold" by Brokerages
August 16, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/inmode-ltd-nasdaqinmd-given-average-recommendation-of-hold-by-brokerages-2026-08-16/
Analysts Have Conflicting Sentiments on These Healthcare Companies: InMode (INMD), GH Research (GHRS) and Scholar Rock Holding (SRRK)
August 9, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/INMD/pressreleases/3739892/analysts-have-conflicting-sentiments-on-these-healthcare-companies-inmode-inmd-gh-research-ghrs-and-scholar-rock-holding-srrk/
InMode: Q2 Earnings Snapshot
August 5, 2026  |  chron.comhttps://www.chron.com/business/article/inmode-q2-earnings-snapshot-22375022.php
InMode Reports Second Quarter 2026 Financial Results: Quarterly GAAP Revenues of $95.6 Million, Consistent with the Second Quarter of 2025
August 5, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/inmode-reports-second-quarter-2026-financial-results-quarterly-gaap-revenues-of-95-6-million-consistent-with-the-second-quarter-of-2025--302842958.html
InMode (NASDAQ:INMD) Governance Update Draws Fresh Focus
July 30, 2026  |  kalkinemedia.comK
Steel Partners Urges InMode Shareholders to Vote AGAINST the Re-Election of Dr. Hadar Ron and AGAINST Extraordinary Special Committee Compensation at the July 30 Annual General Meeting
July 28, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260728880506/en/steel-partners-urges-inmode-shareholders-to-vote-against-the-re-election-of-dr.-hadar-ron-and-against-extraordinary-special-committee-compensation-at-the-july-30-annual-general-meeting/
InMode to Report Second Quarter 2026 Financial Results on August 5, 2026, Expects Q2 Revenue Between $95.2M-$95.4M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M
July 13, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/inmode-to-report-second-quarter-2026-financial-results-on-august-5--2026--expects-q2-revenue-between-95-2m-95-4m-reiterates-fy-2026-revenue-guidance-between-365m-375m-302823516.html
InMode Confirms Receipt of Unsolicited Proposal
July 10, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/inmode-confirms-receipt-of-unsolicited-proposal-302822549.html
Steel Partners offers to acquire InMode at $16.75 per share cash deal; stock rises premarket
July 9, 2026  |  msn.comhttps://www.msn.com/en-us/money/topstocks/steel-partners-offers-to-acquire-inmode-at-1675-per-share-cash-deal-stock-rises-premarket/ar-AA27zndU
InMode shares jump after Steel Partners tables higher takeover proposal (INMD)
July 9, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/inmode-shares-jump-after-steel-partners-tables-higher-takeover-proposal-inmd/ar-AA27znwx
Steel Partners Offers to Acquire InMode for $16.75 Per Share in Cash
July 9, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260709185983/en/steel-partners-offers-to-acquire-inmode-for-16.75-per-share-in-cash/
Securities Fraud Investigation Into InMode Ltd. (INMD) Announced - Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud ...
July 2, 2026  |  tmcnet.comhttps://www.tmcnet.com/usubmit/2026/07/02/10409498.htm
Securities Fraud Investigation Into InMode Ltd. (INMD) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
July 2, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260702173664/en/securities-fraud-investigation-into-inmode-ltd.-inmd-announced-%e2%80%93-shareholders-who-lost-money-urged-to-contact-glancy-prongay-wolke-rotter-llp-a-leading-securities-fraud-law-firm/
Steel Partners comes out against `value-destructive' CEO-led buyout offer for InMode
July 2, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4609329-steel-partners-comes-out-against-value-destructive-ceo-led-buyout-offer-for-inmode

New MarketBeat Followers Over Time

Media Sentiment Over Time

Anteris Technologies Global stock logo

Anteris Technologies Global NASDAQ:AVR

$8.53 -0.09 (-1.04%)
Closing price 09/9/2026 04:00 PM Eastern
Extended Trading
$8.54 +0.01 (+0.06%)
As of 09/9/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

Beta Bionics stock logo

Beta Bionics NASDAQ:BBNX

$17.42 -1.91 (-9.88%)
Closing price 09/9/2026 04:00 PM Eastern
Extended Trading
$17.40 -0.03 (-0.14%)
As of 09/9/2026 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

Electromed stock logo

Electromed NYSE:ELMD

$27.07 -0.44 (-1.60%)
Closing price 09/9/2026 04:00 PM Eastern
Extended Trading
$27.11 +0.04 (+0.15%)
As of 09/9/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

InMode stock logo

InMode NASDAQ:INMD

$14.79 -0.02 (-0.14%)
Closing price 09/9/2026 04:00 PM Eastern
Extended Trading
$14.80 +0.01 (+0.03%)
As of 09/9/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas